Skip to main content

Monsanto Appeals To Toss $78.5M Roundup Verdict

Monsanto Appeals To Toss $78.5M Roundup Verdict

Monsanto Appeals To Toss $78.5M Roundup Verdict

Introduction

On Tuesday, April 23, Monsanto asked a California appeals court to reverse a $78.5 million verdict awarded in the first Roundup trial over the herbicide's alleged cancer risks.

In its appeal, Bayer asserted that there was no evidence that glyphosate detected in Roundup and Roundup Range Pro products could cause cancer. The company said the court must either flip the verdict in its favor or order a new trial, contending that the lower court was wrong in preventing jurors from hearing evidence that the U.S. Environmental Protection Agency and foreign regulators had marked glyphosate as non-carcinogenic to humans. The $78.5 million verdict was a reduced award granted to the plaintiff after Judge Suzanne Bolanos slashed the initially awarded $289 million sanctioned by a San Francisco jury in August 2018.

Bayer, which faces over 13,000 Roundup cancer lawsuits over glyphosate exposure continues to defend itself by proclaiming that decades of scientific research and real-world use have shown glyphosate as safe for humans. U.S. District Judge Vince Chhabria overlooks the federal multidistrict litigation (MDL No. 2741; In Re: Roundup Products Liability Litigation) in the Northern District of California.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!